Arun Wanchoo

Arun Wanchoo

Auto-generated profile, based on publicly available information

Arun Wanchoo

J. Crayton Pruitt Family Department of Biomedical Engineering, Herbert Wertheim College of Engineering, University of Florida, PO Box 116131, Gainesville, FL 32610, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AWArun Wanchoo
Arun Wanchoo
AVAlexandria Voigt
Alexandria Voigt
SSSukesh Sukumaran
Sukesh Sukumaran
CSCarol M. Stewart
Carol M. Stewart
IBIndraneel Bhattacharya
Indraneel Bhattacharya
CNCuong Nguyen
Cuong Nguyen
The development of Sjögren’s syndrome (SjS) is a dynamic and temporal process with a female predilection. Following the initial influx of immune cells, T cell clusters develop, accelerating the pathology in the salivary glands. Proinflammatory cytokines, IFN-γ and IL-17A, produced by T cells contribute synergistically to the disease. In this study, we examined the sexual dimorphism in cellular infiltrates of the salivary glands by using functional single-cell microengraving analysis. Using high-throughput sequencing, we investigated the clonal diversity of the T cell receptors (TCRs) of infiltrating IFN-γ and IL-17A-producing T cells in male and female SjS-susceptible (SjSs) C57BL/6.NOD-Aec1Aec2mice. There were elevated frequencies of IFN-γ and IL-17A-producing effector T cell populations in female SjSSmice compared to male SjSSmice. MEME analysis shows high frequency and unique, sexually dimorphic motifs in the TCR hypervariable regions in the SjSSmice. Male mice selected for TRAV8/TRAJ52 (CATDLNTGANTGKLTFG) TCR genes in Th1 cells and TRBV16/(TRBD1/2)TRBJ1-7 (CGGKRRLESIFR) in Th1 and Th17 cells. Female SjSSmice selected for TRAV8/TRAJ52 (CATDLNTGANTGKLTFG), TRAV13D-2/TRAJ23 (CVYLEHHFE), and TRBV23/(TRBD2)TRBJ2-2 (CRKLHSCATCALNFL) in Th1 cells. These findings suggest that there is an elevated prevalence of pathogenic effector T cells in the glands with a sexually dimorphic selection bias of TCR repertoires.

19 September 2025 in Molecular Systems Design & Engineering
Verified
Journal Article
Open access
PDF file
JSJennifer A. Simonovich
Jennifer A. Simonovich
AWArun Wanchoo
Arun Wanchoo
RCRyan A. Clark
Ryan A. Clark
JPJunha Park
Junha Park
ASAyumi Shigemoto
Ayumi Shigemoto
GHGregory A. Hudalla
Gregory A. Hudalla
Indoleamine 2,3-dioxygenase is an immunomodulatory enzyme that shows great promise when delivered exogenously as a protein therapeutic. However, IDO activity is under complex redox control, mediated in part by multiple cysteine residues within its primary sequence. We have characterized three IDO mutants in which solvent-accessible cysteine residues were mutated to chemically-similar serine residues, “IDOC4S4” with C112S, C159S, C206S, and C308S mutations and “IDOC5S3” with C112S, C159S, and C308S mutations based on prior reports that C206 is necessary for catalytic function, and IDOC0S8, in which all cysteine residues were mutated to serines. IDOC0S8 was expressed in poor yield and demonstrated less than 1% activity when compared to wild-type IDO. In contrast, IDOC4S4 and IDOC5S3 demonstrated robust enzymatic activity, though IDOC5S3 had a slower Vmax than wild-type and IDOC4S4. Computational predictions and experimental measurements suggested a high degree of structural similarity between the wild-type IDO and IDOC4S4, with subtle perturbation of α-helical content for IDOC5S3. The structure of IDOC0S8 was predicted to be significantly different than that of wild-type IDO. IDOC4S4 and IDOC5S3 were more stable than wild-type IDO over time at physiological, ambient, and reduced temperatures, likely due to diminished oxidation of the mutant IDO forms. Based on the increased Vmax and robust thermal stability of IDOC4S4, we fused it to the anchoring moiety galectin 3, to evaluate its effectiveness in a mouse model of psoriasis. The IDOC4S4-galectin-3 fusion blunted the rate and severity of disease as compared to wild-type IDO-galectin-3 fusion. When compared to historical data with Cys-Ala IDO mutants, this study highlights the importance of employing amino acid substitution according to similarity in isosteric and isostructural shape to advance IDO as an immunomodulatory therapeutic.